Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNFα used for the treatment of IBD: Results from the VERNE study.
Bastida G, Marín-Jiménez I, Forés A, García-Planella E, Argüelles-Arias F, Tagarro I, Fernandez-Nistal A, Montoto C, Aparicio J, Aguas M, Santos-Fernández J, Boscá-Watts MM, Ferreiro-Iglesias R, Merino O, Aldeguer X, Cortés X, Sicilia B, Mesonero F, Barreiro-de Acosta M. Bastida G, et al. Among authors: fernandez nistal a. Dig Liver Dis. 2022 Jan;54(1):76-83. doi: 10.1016/j.dld.2021.06.005. Epub 2021 Jul 6. Dig Liver Dis. 2022. PMID: 34244110 Free article.
Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study.
Marin-Jimenez I, Bastida G, Forés A, Garcia-Planella E, Argüelles-Arias F, Sarasa P, Tagarro I, Fernández-Nistal A, Montoto C, Aguas M, Santos-Fernández J, Bosca-Watts MM, Ferreiro R, Merino O, Aldeguer X, Cortés X, Sicilia B, Mesonero F, Barreiro-de Acosta M. Marin-Jimenez I, et al. BMJ Open Gastroenterol. 2020 Mar 26;7(1):e000351. doi: 10.1136/bmjgast-2019-000351. eCollection 2020. BMJ Open Gastroenterol. 2020. PMID: 32337054 Free PMC article.
Clinical characteristics and prognostic factors for Crohn's disease relapses using natural language processing and machine learning: a pilot study.
Gomollón F, Gisbert JP, Guerra I, Plaza R, Pajares Villarroya R, Moreno Almazán L, López Martín MC, Domínguez Antonaya M, Vera Mendoza MI, Aparicio J, Martínez V, Tagarro I, Fernández-Nistal A, Lumbreras S, Maté C, Montoto C; Premonition-CD Study Group. Gomollón F, et al. Among authors: fernandez nistal a. Eur J Gastroenterol Hepatol. 2022 Apr 1;34(4):389-397. doi: 10.1097/MEG.0000000000002317. Eur J Gastroenterol Hepatol. 2022. PMID: 34882644 Free PMC article.
Evaluation of Natural Language Processing for the Identification of Crohn Disease-Related Variables in Spanish Electronic Health Records: A Validation Study for the PREMONITION-CD Project.
Montoto C, Gisbert JP, Guerra I, Plaza R, Pajares Villarroya R, Moreno Almazán L, López Martín MDC, Domínguez Antonaya M, Vera Mendoza I, Aparicio J, Martínez V, Tagarro I, Fernandez-Nistal A, Canales L, Menke S, Gomollón F; PREMONITION-CD Study Group. Montoto C, et al. Among authors: fernandez nistal a. JMIR Med Inform. 2022 Feb 18;10(2):e30345. doi: 10.2196/30345. JMIR Med Inform. 2022. PMID: 35179507 Free PMC article.
Fistulizing perianal lesions in a French population with Crohn's disease.
Wils P, Leroyer A, Fumery M, Fernandez-Nistal A, Gower-Rousseau C, Pariente B. Wils P, et al. Among authors: fernandez nistal a. Dig Liver Dis. 2021 May;53(5):661-665. doi: 10.1016/j.dld.2021.01.010. Epub 2021 Feb 5. Dig Liver Dis. 2021. PMID: 33551356 Free article. No abstract available.
Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an in silico systems biology-based approach.
Carcereny E, Fernández-Nistal A, López A, Montoto C, Naves A, Segú-Vergés C, Coma M, Jorba G, Oliva B, Mas JM. Carcereny E, et al. Among authors: fernandez nistal a. Oncotarget. 2021 Feb 16;12(4):316-332. doi: 10.18632/oncotarget.27875. eCollection 2021 Feb 16. Oncotarget. 2021. PMID: 33659043 Free PMC article.
A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID).
Malchair P, Otero A, Giol J, Solanich X, Carnaval T, Fernández-Nistal A, Sánchez-Gabriel A, Montoto C, Lleonart R, Videla S; ICAT-COVID team. Malchair P, et al. Among authors: fernandez nistal a. Trials. 2022 Apr 12;23(1):303. doi: 10.1186/s13063-022-06219-7. Trials. 2022. PMID: 35413921 Free PMC article.
Effect of recombinant growth hormone on leptin, adiponectin, resistin, interleukin-6, tumor necrosis factor-α and ghrelin levels in growth hormone-deficient children.
López-Siguero JP, López-Canti LF, Espino R, Caro E, Fernández-García JM, Gutiérrez-Macías A, Rial JM, Lechuga JL, Macías F, Martínez-Aedo MJ, Rico S, Rodríguez I, Guillén J, Arroyo FJ, Bernal S, Espigares R, Núñez M, Escribano A, Barrionuevo JL, Gentil J, Barrios V, Fernández-Nistal A, Martos-Moreno GA, Martínez V, Argente J. López-Siguero JP, et al. J Endocrinol Invest. 2011 Apr;34(4):300-6. doi: 10.1007/BF03347090. Epub 2010 Jul 13. J Endocrinol Invest. 2011. PMID: 20634639 Clinical Trial.
20 results